Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Albendazole Tablets USP 200mg, a generic version of Albenza®* tablets (Albendazole Tablets 200mg). Edenbridge intends to begin shipping this newly approved product shortly. For more information please contact the Company directly at info@dexcelpharmausa.com.
Albendazole Tablets, USP Approval
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.